Imgn stock price target
Witryna9 mar 2024 · In predicting price targets of as low as $3.00 and as high as $22.00, analysts are in agreement on assigning the stock over the next 12 months average price target of $12.00. Stock’s current price level is 25.0% above from estimated low price target while it is -450.0% below the estimated high; and even if the IMGN’s share … WitrynaSee ImmunoGen, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Price target. 12.10 …
Imgn stock price target
Did you know?
WitrynaBased on 5 Wall Street analysts offering 12 month price targets for Celldex in the last 3 months. The average price target is $70.00 with a high forecast of $73.00 and a low forecast of $65.00 . The average price target represents a 126.10% change from the last price of $30.96 . WitrynaImmunoGen, Inc. (IMGN) stock forecast and price target. Find the latest ImmunoGen, Inc. IMGN analyst stock forecast, price target, and recommendation trends with in …
WitrynaFind the latest ImmunoGen, Inc. (IMGN) stock quote, history, news and other vital information to help you with your stock trading and investing. Witryna17 mar 2024 · The latest price target for . Immunogen (NASDAQ: IMGN) was reported by HC Wainwright & Co. on March 2, 2024.The analyst firm set a price target for …
Witryna10 kwi 2024 · With analysts defining $3.00-$22.00 as the low and high price targets, we arrive at a consensus price target of $12.00 for the trailing 12-month period. ... IMGN … Witryna17 mar 2024 · The latest price target for . Immunogen (NASDAQ: IMGN) was reported by HC Wainwright & Co. on March 2, 2024.The analyst firm set a price target for $15.00 expecting IMGN to rise to within 12 ...
WitrynaImmunogen (IMGN) Stock Key Data. Summary Additional Data Analysts Historical Quotes. Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.
Witryna14 kwi 2024 · ImmunoGen Inc. (IMGN) current stock price is $4.10. During the last trading session, the stock soared, reaching $4.165 after opening at $3.95. The … chucks romanWitryna1 dzień temu · ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 28, 2024 to discuss its first quarter 2024 operating results. Management will also provide a brief update on … des moines iowa chief of policeWitrynaA. The latest price target for Immunogen ( NASDAQ: IMGN) was reported by HC Wainwright & Co. on Thursday, March 2, 2024. The analyst firm set a price target for 15.00 expecting IMGN to rise to ... des moines iowa bridal showsWitryna10 kwi 2024 · With analysts defining $3.00-$22.00 as the low and high price targets, we arrive at a consensus price target of $12.00 for the trailing 12-month period. ... IMGN stock’s performance was 4.37% in the latest trading, and -26.71% in the past year, while Eli Lilly and Company (LLY) has traded 1.67% on the day and positioned 25.92% … des moines iowa civic center seating chartWitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian … des moines iowa bus stationWitryna3 lut 2024 · ImmunoGen, Inc. is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company’s technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of its potent anti-cancer … chucks rolling video gamesWitryna6 kwi 2024 · Immunogen started at buy with $10 stock price target at Truist Nov. 21, 2024 at 7:42 a.m. ET by Tomi Kilgore ImmunoGen's stock is up 12% after the FDA accepts application for new ovarian-cancer ... des moines iowa diversity